ERBB2 and breast carcinoma: Among various subtypes of breast cancer (Luminal A/B, basal-like and human epidermal growth receptor 2 (HER2) enriched) identified by transcriptomic analyses of breast tumors, basal-like breast cancer is one of the most aggressive subtypes [3,4,5].